Citations

Showing 10 of 108094 citations.

Trends in Carotid Revascularization Procedures—Reply
Lichtman, Judith H. , Howard, George , Brott, Thomas G. , Howard, George

Mayo Clinic

JAMA | January 16, 2018 | Volume: 319 | Issue: 3 | Pages: 308

10.1001/jama.2017.19781 | PMID 29340674 Get It

Labyrinthine Sequestrum: A Case Report and Review of the Literature
Vork, Diana L., Eguiguren, Lourdes , Driscoll, Colin L. W., Carlson, Matthew L. , Henry, Nancy K., Lane, John I. , Guérin, J. , Vork, Diana L. , Marston, Alexander P.

Mayo Clinic

Otology & Neurotology | January 16, 2018 | Volume: 39 | Issue: 3 | Pages: 340-343

10.1097/mao.0000000000001676 | PMID 29337715 Get It

Objective: To report the presentation, diagnosis, management, and convalescence of labyrinthine sequestrum (LS) and summarize all previously published cases. Patient(s): Eleven-year-old female with LS. Intervention(s): Multidisciplinary diagnostic evaluation and treatment. Main Outcome Measures: Imaging and laboratory findings, medical and surgical treatment. Results: We describe a case of LS secondary to medically recalcitrant suppurative otitis media in an 11-year-old female and review all eight previously reported cases. The index patient presented after 6 months of otitis media, profound unilateral hearing loss, with symptoms suggesting meningitis. Temporal bone CT demonstrated marked bony destruction of the left otic capsule. Gadolinium-enhanced MRI showed an enhancing process with evidence of meningitis and subdural empyema. The patient was treated with surgical debridement and culture directed antibiotic therapy. Posttreatment imaging showed resolution of intracranial infection with fibrous bony healing of the otic capsule resembling fibrous dysplasia. Conclusion: LS is a rare form of labyrinthitis characterized by centrifugal destruction of the otic capsule. The current index case highlights the importance of combined medical and surgical treatment and describes for the first time in the literature the fibrous ossification of the otic capsule following disease resolution.
Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A 1c , LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study
Ikramuddin, Sayeed , Körner, Judith , Thomas, Avis J., Connett, John E. , Bantle, John P., Leslie, Daniel B. , Wang, Qi , Inabnet, William B. , Jeffery, Robert W., Chong, Keong , Chuang, Lee‐Ming , Jensen, Michael D. , Ahmed, Leaque , Belani, Kumar G. , Lee, Wei‐Jei , Vella, Adrian , Billington, Charles J.

Mayo Clinic

JAMA | January 16, 2018 | Volume: 319 | Issue: 3 | Pages: 266

10.1001/jama.2017.20813 | PMID 29340678 Get It

Evaluating the validity of subclassifying warfarin‐associated nonuremic calciphylaxis: a retrospective cohort study
Lehman, Julia S. , Chen, Tiffany , Lohse, Christine M. , Chen, Tiffany Y, El-Azhary, Rokea A, Lehman, Julia S , el‐Azhary, Rokea A.

Mayo Clinic

International Journal of Dermatology | January 16, 2018 | Volume: 57 | Issue: 5 | Pages: 572-574

10.1111/ijd.13884 | PMID 29336027 Get It

AbstractBackgroundCalciphylaxis is a devastating multifactorial disorder of the subcutaneous fat that is known to be associated with hypercoagulability. Recent literature has proposed subclassifying patients with calciphylaxis as having warfarin‐associated or warfarin‐unassociated disease.AimWe aimed to determine whether patients with warfarin‐associated calciphylaxis differ clinically from patients with warfarin‐unassociated calciphylaxis.Materials and methodsWe performed a subgroup analysis of patients with nonuremic calciphylaxis from a previously studied cohort and compared clinical and outcomes features of patients who were taking warfarin at the time of disease onset to those of patients who were not.ResultsNineteen patients with nonuremic calciphylaxis were identified, including 10 (53%) who had been on warfarin at the time of disease onset and 9 (47%) who had not. Of all clinical and outcomes parameters tested, no significant differences were detected between the two groups.Discussion and ConclusionsThough this study is limited by its retrospective nature and the relatively small number of patients studied, available data do not support subclassifying patients with nonuremic calciphylaxis as having warfarin‐associated or warfarin‐unassociated disease. Rather, the body of literature would suggest that identification and correction of underlying disorders of hypercoagulability should be prioritized.
Use of Intraoperative Negative Margins Reduces Inverted Papilloma Recurrence
Miglani, Amar , Zarka, Matthew A., Hoxworth, Joseph M. , Lal, Devyani

Mayo Clinic

American Journal of Rhinology & Allergy | January 16, 2018 | Volume: 32 | Issue: 1 | Pages: 57-60

10.2500/ajra.2018.32.4504 | PMID 29336292 Get It

Background Recurrence of inverted papilloma (IP) is a problem in 12–17% of tumors. Controversy exists regarding benefits of intraoperative frozen section histopathology (IFSH) for IP resection; however, to our knowledge, no study has specifically investigated this. IFSH for IP resection is the standard of care in our practice. We, therefore, reviewed our outcomes of using IFSH for IP resection. A secondary goal was to assess the reliability of IFSH. Methods Patients with IP who underwent surgical resection (2010–2016) with minimum 9–month follow-up were included. Results Twenty-two adults with IP met inclusion criteria. All underwent surgery via endoscopic techniques, supplemented by external ports in five patients. At the time of presentation, 36% IPs were recurrent tumors; 68% were graded as Krouse stage 3. Resection was conducted until “clear” (negative) mucosal margins were achieved on IFSH. In 6 (27%), a “positive” IFSH result dictated additional resection to clear margins. Final negative margins were achieved in all the patients. Both positive and negative predictive values for IFSH were 100% (concordance with final pathology results). Surveillance was performed every 1–6 months with nasal endoscopy by using imaging when necessary. No recurrences were noted (0%) at mean follow-up of 40 months (range, 10 -73 months). Conclusions Positive IFSH results led to increased resection in 27% of the patients, with a 0% recurrence rate in this cohort. The reliability of IFSH for IP is very high. No recurrence of IP was noted in any patient at a mean follow-up of 3.3 years. IFSH may help reduce recurrence rates of IP, but additional studies with longer follow-up are warranted.
Evaluations of UltraiQ software for objective ultrasound image quality assessment using images from a commercial scanner
Long, Zaiyang , Tradup, Donald J., Stekel, Scott F. , Gorny, Krzysztof R. , Hangiandreou, Nicholas J.

Mayo Clinic

Journal of Applied Clinical Medical Physics | January 16, 2018 | Volume: 19 | Issue: 2 | Pages: 298-304

10.1002/acm2.12255 | PMID 29336119 Get It

AbstractWe evaluated a commercially available software package that uses B‐mode images to semi‐automatically measure quantitative metrics of ultrasound image quality, such as contrast response, depth of penetration (DOP), and spatial resolution (lateral, axial, and elevational). Since measurement of elevational resolution is not a part of the software package, we achieved it by acquiring phantom images with transducers tilted at 45 degrees relative to the phantom. Each measurement was assessed in terms of measurement stability, sensitivity, repeatability, and semi‐automated measurement success rate. All assessments were performed on a GE Logiq E9 ultrasound system with linear (9L or 11L), curved (C1‐5), and sector (S1‐5) transducers, using a CIRS model 040GSE phantom. In stability tests, the measurements of contrast, DOP, and spatial resolution remained within a ±10% variation threshold in 90%, 100%, and 69% of cases, respectively. In sensitivity tests, contrast, DOP, and spatial resolution measurements followed the expected behavior in 100%, 100%, and 72% of cases, respectively. In repeatability testing, intra‐ and inter‐individual coefficients of variations were equal to or less than 3.2%, 1.3%, and 4.4% for contrast, DOP, and spatial resolution (lateral and axial), respectively. The coefficients of variation corresponding to the elevational resolution test were all within 9.5%. Overall, in our assessment, the evaluated package performed well for objective and quantitative assessment of the above‐mentioned image qualities under well‐controlled acquisition conditions. We are finding it to be useful for various clinical ultrasound applications including performance comparison between scanners from different vendors.
Five-Year Mortality After Transient Ischemic Attack
Yousufuddin, Mohammed , Keenan, Lawrence R., Olson, Tammy, Shultz, Jessica, Doyle, Taylor, Ahmmad, Eimad M. , Arumaithurai, Kogulavadanan , Takahashi, Paul Y. , Murad, M. Hassan , Young, Nathan, Keenan, Lawrence, Takahashi, Paul, Murad, Mohammad Hassan, Murad, M Hassan , Takahashi, Paul , Young, Nathan P.

Mayo Clinic

Stroke | January 16, 2018 | Volume: 49 | Issue: 3 | Pages: 730-733

10.1161/strokeaha.117.020022 | PMID 29339433 Get It

Background and Purpose— We aimed at providing estimates of mortality associated with cardiometabolic comorbidity and incident readmission from cardiometabolic as compared with noncardiometabolic conditions after a first transient ischemic attack. Methods— Between 2000 and 2015, patients hospitalized for a first transient ischemic attack were examined for cardiometabolic comorbidities (diabetes mellitus, coronary artery disease, heart failure, and atrial fibrillation), 5-year incident hospitalization, and time to death. Results— Of 251 patients with transient ischemic attack, 134 (53%) had at least 1 and 55 (22%) had at least 2 cardiometabolic conditions. By 5 years, 491 readmissions (134 [27%] cardiometabolic and 357 [73%] noncardiometabolic) and 75 deaths (27 [36%] cardiometabolic and 47 [64%] noncardiometabolic) were observed. Mortality was increased with any concurrent cardiometabolic comorbidity (hazard ratio, 1.89; 95% confidence interval, 1.17–3.03; P =0.0089) with multiplicative mortality risk from a combination of coronary artery disease and heart failure. Each hospitalization was associated with a 1.5-fold risk of death (95% confidence interval, 1.37–1.64; P <0.0001). Risk of cardiometabolic and noncardiometabolic mortality was correlated with the corresponding category-specific readmission. Conclusions— Among patients hospitalized for first transient ischemic attack, 5-year mortality is associated with concurrent cardiometabolic comorbidity and rates of subsequent hospitalization.
Long‐term surveillance of SUDEP in drug‐resistant epilepsy patients treated with VNS therapy
Ryvlin, Philippe , So, Elson L., Gordon, Charles M. , Hesdorffer, Dale C. , Sperling, Michael R. , Devinsky, Orrin , Bunker, Mark , Olin, Bryan, Friedman, Daniel , Ryvlin, Philippe , Sperling, Michael R , Devinsky, Orrin

Mayo Clinic

Epilepsia | January 16, 2018 | Volume: 59 | Issue: 3 | Pages: 562-572

10.1111/epi.14002 | PMID 29336017 Get It

Summary Objective Limited data are available regarding the evolution over time of the rate of sudden unexpected death in epilepsy patients (SUDEP) in drug‐resistant epilepsy. The objective is to analyze a database of 40 443 patients with epilepsy implanted with vagus nerve stimulation (VNS) therapy in the United States (from 1988 to 2012) and assess whether SUDEP rates decrease during the postimplantation follow‐up period. Methods Patient vital status was ascertained using the Centers for Disease Control and Prevention's National Death Index (NDI). An expert panel adjudicated classification of cause of deaths as SUDEP based on NDI data and available narrative descriptions of deaths. We tested the hypothesis that SUDEP rates decrease with time using the Mann‐Kendall nonparametric trend test and by comparing SUDEP rates of the first 2 years of follow‐up (years 1‐2) to longer follow‐up (years 3‐10). Results Our cohort included 277 661 person‐years of follow‐up and 3689 deaths, including 632 SUDEP. Primary analysis demonstrated a significant decrease in age‐adjusted SUDEP rate during follow‐up ( S = −27 P = .008), with rates of 2.47/1000 for years 1‐2 and 1.68/1000 for years 3‐10 (rate ratio 0.68; 95% confidence interval [CI] 0.53‐0.87; P = .002). Sensitivity analyses confirm these findings. Significance Our data suggest that SUDEP risk significantly decreases during long‐term follow‐up of patients with refractory epilepsy receiving VNS Therapy. This finding might reflect several factors, including the natural long‐term dynamic of SUDEP rate, attrition, and the impact of VNS Therapy. The role of each of these factors cannot be confirmed due to the limitations of the study.
Topographic Analysis of the Distal Femoral Condyle Articular Cartilage Surface: Adequacy of the Graft from Opposite Condyles of the Same or Different Size for the Osteochondral Allograft Transplantation
Yanke, Adam B. , Shin, Jason J. , Cvetanovich, Greg L., Moran, Erin K., Bach, Bernard R. , Cole, Brian J. , Inoue, Nozomu , Verma, Nikhil N. , Urita, Atsushi , Moran, Erin K. , Bach, Bernard R.

Mayo Clinic

CARTILAGE | January 16, 2018 | Volume: 10 | Issue: 2 | Pages: 205-213

10.1177/1947603517752056 | PMID 29334769 Get It

Objective To analyze the topography of the opposite condyle to treat focal femoral condyle articular defects with an osteochondral allograft (OCA). Design Three groups were created: Group 1, same condyle with same width; Group 2, opposite condyle with same width; Group 3, opposite condyle with different width. Computed tomography (CT) of 22 cadaveric femoral hemi-condyles was used to create 3-dimensional CT models that were exported into point-cloud models. Three zones of the donor condyle (anterior, middle, and posterior) were quantified. Four defect sizes were created (15, 18, 23, 25 mm) at the weight-bearing region. The defect was moved throughout each donor condyle zone and the least distance was calculated, defined as the shortest distance between the defect and the donor condyle. Results The mean least distance increased with larger defect size in all groups, yet there was a less than 0.2 mm difference in the least distance among defect sizes. The 15, 18, and 23 mm defect models in Group 1 exhibited greater least distances at the anterior than middle and posterior zones. The 15 mm defect model exhibited greater least distance at the anterior zone than posterior zone in Group 3. However, there was a less than 0.05 mm difference in the mean least distance between zones. There was no significant difference in the least distance between groups. Conclusion OCAs from opposite condyles yield similar topographic matching to OCAs from the same condyles, suggesting that opposite condyles can be utilized. Clinical correlation and outcomes are necessary.